Cargando…
A network-based drug repurposing method via non-negative matrix factorization
MOTIVATION: Drug repurposing is a potential alternative to the traditional drug discovery process. Drug repurposing can be formulated as a recommender system that recommends novel indications for available drugs based on known drug-disease associations. This article presents a method based on non-ne...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8825773/ https://www.ncbi.nlm.nih.gov/pubmed/34875000 http://dx.doi.org/10.1093/bioinformatics/btab826 |
_version_ | 1784647288409292800 |
---|---|
author | Sadeghi, Shaghayegh Lu, Jianguo Ngom, Alioune |
author_facet | Sadeghi, Shaghayegh Lu, Jianguo Ngom, Alioune |
author_sort | Sadeghi, Shaghayegh |
collection | PubMed |
description | MOTIVATION: Drug repurposing is a potential alternative to the traditional drug discovery process. Drug repurposing can be formulated as a recommender system that recommends novel indications for available drugs based on known drug-disease associations. This article presents a method based on non-negative matrix factorization (NMF-DR) to predict the drug-related candidate disease indications. This work proposes a recommender system-based method for drug repurposing to predict novel drug indications by integrating drug and diseases related data sources. For this purpose, this framework first integrates two types of disease similarities, the associations between drugs and diseases, and the various similarities between drugs from different views to make a heterogeneous drug–disease interaction network. Then, an improved non-negative matrix factorization-based method is proposed to complete the drug–disease adjacency matrix with predicted scores for unknown drug–disease pairs. RESULTS: The comprehensive experimental results show that NMF-DR achieves superior prediction performance when compared with several existing methods for drug–disease association prediction. AVAILABILITY AND IMPLEMENTATION: The program is available at https://github.com/sshaghayeghs/NMF-DR. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online. |
format | Online Article Text |
id | pubmed-8825773 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-88257732022-02-09 A network-based drug repurposing method via non-negative matrix factorization Sadeghi, Shaghayegh Lu, Jianguo Ngom, Alioune Bioinformatics Original Papers MOTIVATION: Drug repurposing is a potential alternative to the traditional drug discovery process. Drug repurposing can be formulated as a recommender system that recommends novel indications for available drugs based on known drug-disease associations. This article presents a method based on non-negative matrix factorization (NMF-DR) to predict the drug-related candidate disease indications. This work proposes a recommender system-based method for drug repurposing to predict novel drug indications by integrating drug and diseases related data sources. For this purpose, this framework first integrates two types of disease similarities, the associations between drugs and diseases, and the various similarities between drugs from different views to make a heterogeneous drug–disease interaction network. Then, an improved non-negative matrix factorization-based method is proposed to complete the drug–disease adjacency matrix with predicted scores for unknown drug–disease pairs. RESULTS: The comprehensive experimental results show that NMF-DR achieves superior prediction performance when compared with several existing methods for drug–disease association prediction. AVAILABILITY AND IMPLEMENTATION: The program is available at https://github.com/sshaghayeghs/NMF-DR. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online. Oxford University Press 2021-12-07 /pmc/articles/PMC8825773/ /pubmed/34875000 http://dx.doi.org/10.1093/bioinformatics/btab826 Text en © The Author(s) 2021. Published by Oxford University Press. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Papers Sadeghi, Shaghayegh Lu, Jianguo Ngom, Alioune A network-based drug repurposing method via non-negative matrix factorization |
title | A network-based drug repurposing method via non-negative matrix factorization |
title_full | A network-based drug repurposing method via non-negative matrix factorization |
title_fullStr | A network-based drug repurposing method via non-negative matrix factorization |
title_full_unstemmed | A network-based drug repurposing method via non-negative matrix factorization |
title_short | A network-based drug repurposing method via non-negative matrix factorization |
title_sort | network-based drug repurposing method via non-negative matrix factorization |
topic | Original Papers |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8825773/ https://www.ncbi.nlm.nih.gov/pubmed/34875000 http://dx.doi.org/10.1093/bioinformatics/btab826 |
work_keys_str_mv | AT sadeghishaghayegh anetworkbaseddrugrepurposingmethodvianonnegativematrixfactorization AT lujianguo anetworkbaseddrugrepurposingmethodvianonnegativematrixfactorization AT ngomalioune anetworkbaseddrugrepurposingmethodvianonnegativematrixfactorization AT sadeghishaghayegh networkbaseddrugrepurposingmethodvianonnegativematrixfactorization AT lujianguo networkbaseddrugrepurposingmethodvianonnegativematrixfactorization AT ngomalioune networkbaseddrugrepurposingmethodvianonnegativematrixfactorization |